Signals Blog
Menu

Nick Dragojlovic

Nick Dragojlovic is a health services researcher at the University of British Columbia's Faculty of Pharmaceutical Sciences. He has previously held postdoctoral fellowships at the University of Calgary and at UBC, and has received funding from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research. He holds a BA from Yale University and an MA and PhD from UBC. Nick is particularly interested in the use of alternative finance mechanisms to support scientific research, and covers the topic on his blog: Funded Science

Posts by: Nick


The race to develop senescent cell clearance therapies

A growing focus of biomedical research and regenerative medicine is the effort to target the aging process itself, by either slowing or reversing the accumulation of cellular and molecular damage that drives age-related functional decline. The goal is to develop new treatments for age-related chronic diseases, which are the leading cause of death in the […]

How online outreach adds value to scientific research

> Scientists: I have some questions. Have you ever written a blog post about your field? Tweeted a link to a new scientific publication? Joined a forum discussion about the latest research? As it turns out, your likelihood of answering “yes” to one or more of these questions is no better than a coin flip. […]

Update on crowdfunding in the regenerative medicine space

> In a recent post on Signals, David Kent made the case for government-funded clinical trials of autologous stem cell therapies, since the lack of proven commercialization models in this area make it difficult to attract private investment. Another way of financing the clinical translation of stem cell therapies with limited commercialization potential is the […]

Why clinical translation is key to CIRM’s quest for more funding

> As the expiration of the California Institute for Regenerative Medicine’s (CIRM) funding approaches, the fate of CIRM after 2017 is top of mind for stem cell researchers in the state. While the agency’s leadership appears to be leaning towards some form of public-private partnership, planning for its financial future has reportedly assumed the future […]

Science Idol: Could regenerative medicine R&D be crowdfunded?

Would you use/support crowdfunding for research? Take the survey at the end of this post. . Biomedical research is expensive, and existing sources of funding often fall short. Profitable business models for the development of cell-based therapies are still being worked out, so investment in regenerative medicine start-ups can be difficult to secure. Foundations and […]